Market Cap
$516.4M
AUTL
Autolus Therapeutics plc
$1.78 ▼ -3.78%
Prev close $1.85Market cap$516.4M
ConsensusStrong Buy
12-mo target$8.73 (+390.2%)
▲ Bullish
Analyst conviction 9/10
High Impact Filing (7/10)8 New Institutional Positions4 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on AUTL right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Strong Buy (94%)
Inst. Holders
49 funds
Inst. Value
$76.7M
Inst. Activity
8 buys / 4 sells
Insider Activity
$0.00 buy / $15.7K sell
Insider Net $
-$15.7K
SEC Reports
9
Press Releases
4
Price chart 30d -22.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 29, 2026 short_volume
Sep 14, 2026 SEC Short Volume: AUTL — 57.7% short (0.5M / 0.9M)
Short: 519,167 | Exempt: 0 | TRF Vol: 899,715 | Short Ratio: 57.7% | Off-exchange volume (dark pool
Autolus Therapeutics filed an S-3 registration statement to register 3,500,000 ADSs for resale by Perceptive Credit Hold
S-3 — Impact 4/10
Sep 2, 2026 Insider
Piccina Cintia sold 6,713 shares
U.S. CCO & Country Gen Manager @ $2.34 ($15.7K)
Sep 1, 2026 Insider
Aug 11, 2026 SEC Piccina Cintia acquired via exercise 20,000 shares
U.S. CCO & Country Gen Manager @ $2.35 ($47.0K)
Autolus Therapeutics reported Q2 2026 AUCATZYL net product revenue of $45.7M, up 119% YoY, and raised FY 2026 guidance t
8-K — Impact 7/10
Autolus Therapeutics raised FY2026 AUCATZYL net product revenue guidance to $140M-$150M (from $120M-$135M) and reported
8-K — Impact 7/10
Jun 30, 2026 Inst.
MORGAN STANLEY — ADD
1,260,832 shares ($2.0M)
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — DOUBLED
1,224,818 shares ($2.0M)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
94% rate it Buy or better · 16 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 3, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| May 14, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Apr 9, 2026 | Needham | REITERATE | Buy | 50% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 6 | 9 | 1 | 0 | 0 | 94% | |
| Aug 1, 2026 | 6 | 9 | 1 | 0 | 0 | 94% | |
| Jul 1, 2026 | 6 | 9 | 1 | 0 | 0 | 94% | |
| Jun 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% | |
| May 1, 2026 | 6 | 11 | 1 | 0 | 0 | 94% | |
| Apr 1, 2026 | 6 | 11 | 1 | 0 | 0 | 94% | |
| Mar 1, 2026 | 6 | 11 | 1 | 0 | 0 | 94% | |
| Feb 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% |
Price targets
Where 8 covering analysts think AUTL trades over the next 12 months.
$8.73 +390.2% upside Strong Buy
Current$1.78 Low$5.00 Median$9.50 High$11.00 8 analysts
$5.00$11.00
Analyst rating Strong Buy· 1.1/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
9 SEC filing reports analyzed · 3 bullish, 2 bearish, 2 mixed, 2 neutral · avg impact 6.1/10.Plus 4 press releases.
NEUTRALS-34/10
Autolus Therapeutics filed an S-3 registration statement to register 3,500,000 ADSs for resale by Pe
Sep 14, 2026
BULLISH8-K7/10
Autolus Therapeutics reported Q2 2026 AUCATZYL net product revenue of $45.7M, up 119% YoY, and raise
Aug 11, 2026
BULLISH8-K7/10
Autolus Therapeutics raised FY2026 AUCATZYL net product revenue guidance to $140M-$150M (from $120M-
Aug 3, 2026
NEUTRAL8-K6/10
Autolus Therapeutics entered into a $250M senior secured notes facility with Perceptive Credit Holdi
Aug 3, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 29, 2026
short_volume
Short Volume: AUTL — 57.7% short (0.5M / 0.9M)
Short: 519,167 | Exempt: 0 | TRF Vol: 899,715 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: AUTL — 59.8% short (0.4M / 0.7M)
Short: 405,716 | Exempt: 7,246 | TRF Vol: 678,401 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: AUTL — 58.7% short (0.4M / 0.7M)
Short: 405,642 | Exempt: 0 | TRF Vol: 690,569 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
Sep 11, 2026
short_volume
Short Volume: AUTL — 55.7% short (0.6M / 1.0M)
Short: 571,497 | Exempt: 0 | TRF Vol: 1,026,725 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
Aug 14, 2026
short_interest_report
Short Interest: AUTL down 24% to 10.5M shares
Settlement 2026-08-14 | Days to cover: 2.39 | ≈3.94% of shares outstanding (est.)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.16 | $-0.20–$-0.10 | 46.1% | +0.0% | 6↑ 0↓ | $0.0B | 6 |
| Next Q | $-0.17 | $-0.20–$-0.13 | 49.5% | +0.0% | 5↑ 1↓ | $0.0B | 6 |
| Current FY | $-0.79 | $-0.97–$-0.61 | 26.6% | +0.0% | 7↑ 1↓ | $0.1B | 8 |
| Next FY | $-0.63 | $-0.97–$-0.31 | 20.9% | +0.0% | 3↑ 4↓ | $0.2B | 8 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.162 | — |
| 7d ago | $-0.162 | — |
| 30d ago | $-0.162 | — |
| 60d ago | $-0.208 | +0.047 |
| 90d ago | $-0.214 | +0.052 |
Institutional ownership
Which big funds own AUTL (from quarterly 13F filings) and who is adding or trimming.
49 institutional holders with $76.7M total value (47,726,109 shares) as of 2026-Q2. Top holders: Blackstone, SCHRODER, BNP. Net buying activity: 8 institutions added/increased vs 4 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| Blackstone Inc. | 20,485,611 | $32.8M | 42.8% | EXIT -100.0% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 7,833,282 | $12.9M | 16.9% | DOUBLED +133.7% |
| BNP Paribas Asset Management Holding S.A. | 3,361,156 | $5.4M | 7.0% | — |
| RENAISSANCE TECHNOLOGIES LLC | 1,984,700 | $3.2M | 4.1% | TRIM -26.0% |
| BANK OF AMERICA CORP /DE/ | 1,605,092 | $2.6M | 3.3% | DOUBLED +108.1% |
| BlackRock, Inc. | 1,603,458 | $2.6M | 3.3% | TRIM -59.8% |
| UBS Group AG | 1,516,991 | $2.4M | 3.2% | ADD +48.9% |
| MORGAN STANLEY | 1,260,832 | $2.0M | 2.6% | ADD +33.9% |
| MILLENNIUM MANAGEMENT LLC | 1,224,818 | $2.0M | 2.6% | DOUBLED +498.3% |
| Cetera Investment Advisers | 1,157,324 | $1.9M | 2.4% | ADD +37.3% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 941,823 | 1,260,832 | +33.9% | $2.0M |
| MILLENNIUM MANAGEMENT LLC | DOUBLED | 204,728 | 1,224,818 | +498.3% | $2.0M |
| CITADEL ADVISORS LLC | ADD | 459,404 | 695,890 | +51.5% | $1.1M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | TRIM | 399,143 | 177,232 | -55.6% | $283.6K |
| Quadrature Capital Ltd | DOUBLED | 54,733 | 114,883 | +109.9% | $183.8K |
| MARSHALL WACE, LLP | DOUBLED | 26,682 | 94,654 | +254.7% | $151.4K |
| Point72 Asset Management, L.P. | NEAR_EXIT | 426,983 | 71,227 | -83.3% | $114.0K |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 45,749 | 25,192 | -44.9% | $40.3K |
| QRG CAPITAL MANAGEMENT, INC. | ADD | 10,925 | 18,325 | +67.7% | $29.3K |
| Marex Group Ltd | NEAR_EXIT | 542,857 | 17,857 | -96.7% | $28.6K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
10 insiders, 20 transactions. Net -$15.7K — $0.00 bought, $15.7K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Piccina Cintia | U.S. CCO & Country Gen Manager | SELL | 6,713 | $2.34 | $15.7K |
| Sep 1, 2026 | Piccina Cintia | U.S. CCO & Country Gen Manager | EXERCISE | 20,000 | $2.35 | $47.0K |
| Jun 29, 2026 | YOUNG WILLIAM D | Director | AWARD | 31,667 | — | — |
| Jun 29, 2026 | BONNEY MICHAEL W | Director | AWARD | 31,667 | — | — |
| Jun 29, 2026 | BUTITTA CYNTHIA M | Director | AWARD | 31,667 | — | — |
| Jun 29, 2026 | BUTITTA CYNTHIA M | Director | AWARD | 47,500 | — | — |
| Jun 29, 2026 | Iannone Robert | Director | AWARD | 31,667 | — | — |
| Jun 29, 2026 | Leiderman Elisabeth | Director | AWARD | 47,500 | — | — |
| Jun 29, 2026 | Richardson Ryan | Director | AWARD | 31,667 | — | — |
| Jun 29, 2026 | Richardson Ryan | Director | AWARD | 47,500 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for AUTL.
Shares short
8,325,703
Settlement Sep 15, 2026
Change vs prior
-8.3%
Semi-monthly cycle
Days to cover
4.8
At avg daily volume
Of shares outstanding
≈3.1%
Estimate — not % of float
All AUTL filing & press-release reports (13)
- S-3 reportSep 14, 2026
- 8-K reportAug 11, 2026
- 8-K reportAug 3, 2026
- 8-K reportAug 3, 2026
- PRESS-RELEASE reportJun 12, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportJun 9, 2026
- PRESS-RELEASE reportMay 21, 2026
- 8-K reportMay 14, 2026
- PRESS-RELEASE reportMay 14, 2026
- PRESS-RELEASE reportApr 21, 2026
- 8-K reportApr 8, 2026
- PRESS-RELEASE reportMar 16, 2026